Month: April 2020

WILMINGTON, N.C., April 08, 2020 (GLOBE NEWSWIRE) — Live Oak Bancshares, Inc. (“Live Oak”) (Nasdaq: LOB) today announced that it will report its first quarter 2020 financial results after U.S. financial markets close on Wednesday, April 22, 2020.In conjunction with this announcement, Live Oak will host a conference call to discuss the company’s financial results and business outlook on Thursday, April 23, 2020, at 9:00 a.m. ET. To access this call, dial (844) 743-2494 (domestic) or (661) 378-9528 (international) with conference ID 9470049. A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.liveoakbank.com/. After the conference call, a replay will be available until April 30, 2020, and can be accessed by dialing (855) 859-2056 (domestic)...

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems” or the “Company”) (TSX:WPRT / Nasdaq:WPRT) today announced that in response to the ongoing global COVID-19 pandemic, it will host its upcoming Annual and Special Meeting of shareholders (the “Meeting”) in a virtual only format, at the same date and time as originally planned, being April 29, 2020 at 10:00 am Pacific Time.The health and wellbeing of Westport Fuel Systems’ employees, service partners and shareholders is of utmost importance. As the impact of COVID-19 continues to evolve and to ensure compliance with public health measures enacted by the province of British Columbia, the Meeting will be conducted in a virtual only format. Shareholders will no longer be able to attend the Meeting in person as previously...

MCLEAN, Va., April 08, 2020 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (Nasdaq: GOOD) (“Gladstone Commercial”) announced that it has closed a $1.0 Million Property Assessed Clean Energy (“PACE”) financing for its 260 Springside property in Akron, OH. The rate on the financing is 3.5%. The 84,000 SF single-story multi-tenant office building is 74% leased to Flexsys America L.P. (a subsidiary of Eastman Chemical Company) providing lab and office space for its Tire Additives Technology Center of Excellence. The financings cover 100% of the costs to replace a large portion of the building’s HVAC equipment including conversion from electric to gas for many units, to modernize fume hood controls, to install energy efficient interior lighting, and to tie all of it into a robust energy management system installed in 2019 allowing...

BELLINGHAM, Wash., April 08, 2020 (GLOBE NEWSWIRE) — eXp Realty, the fastest-growing, global residential real estate company and a subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced preliminary first-quarter 2020 business highlights and measures to address challenges of the near future real estate environment.First-quarter 2020 Preliminary Business Highlights (unaudited):The number of agents and brokers on the eXp Realty platform increased 59% to 28,449 at the end of the first quarter of 2020, compared to 17,929 a year ago.Residential transaction sides closed for the first quarter of 2020 increased 73% to more than 38,000, compared to 22,307 during the first quarter of 2019.Residential transaction volume closed for the first quarter of 2020 increased 93% to $11.2 billion, compared to $5.8 billion during the first...

MENLO PARK, Calif., April 08, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at the 19th Annual Needham Virtual Healthcare Conference at 10:00 a.m. ET on Wednesday, April 15, 2020.A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentation, an archived webcast will be available on the Company’s website for 30 days.About GeronGeron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.CONTACT:Suzanne...

 FDA Authorizes Use of PB560 in the United States Company Launches PB980 Remote Capabilities Medtronic Expects Five-Fold Increase in Its Ventilator Production by End of JuneDUBLIN, April 08, 2020 (GLOBE NEWSWIRE) —  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced updates regarding its efforts to increase ventilator production around the globe. The company is announcing solid progress in the ramp-up of its ventilator production, as well as collaborating with technology partners and governments to drive new ventilator innovation and production, all in support of COVID-19 patients worldwide.

Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 31, 2018)Significant milestones achieved in 2019:Release of full dataset from the successful Phase 2 clinical trial of elafibranor in PBC, leading to “Breakthrough Therapy” and “Orphan Drug” designationsStrategic partnership with Terns Pharmaceuticals for the development and commercialization of elafibranor in Greater China, and strategic R&D agreement ($35MM upfront payment, and up to $193MM in milestones payment)Licensing agreement with LabCorp-Covance for NIS4, a non-invasive diagnostic tool for the identification of NASH patients with fibrosisGlobal offering and U.S. IPO on Nasdaq, raising gross proceeds totaling $155MMChange in governance and strengthening of US...

Résultats intermédiaires de l’essai clinique de Phase 3 RESOLVE-IT attendus d’ici fin mai 2020Position de trésorerie à 277MM€ au 31/12/2019 (vs 207MM€ au 31/12/2018)Avancées significatives en 2019 :Présentation des données complètes de l’essai positif de Phase 2 évaluant elafibranor dans la PBC, suivie de l’obtention des désignations « Breakthrough Therapy » et « Orphan Drug »Partenariat stratégique avec Terns Pharmaceuticals pour le développement et la commercialisation d’elafibranor dans la région Grande Chine, et accord stratégique de R&D (upfront de 35MM$, et jusqu’à 193MM$ en milestones)Accord de licence avec Labcorp-Covance pour NIS4, outil de diagnostic non-invasif pour l’identification de patients NASH avec fibroseCotation sur le Nasdaq, et levée de fonds associée pour un montant brut total de 155MM$ par voie d’augmentation...

CALGARY, Alberta, April 08, 2020 (GLOBE NEWSWIRE) — Inventronics Limited (“Corporation”) (IVX:TSX Venture), a designer and manufacturer of custom enclosures for the telecommunications, electric transmission, cable television and other industries in North America, today announced its 2019 audited annual and unaudited 2019 Q4 financial results.For the year ended December 31, 2019, the Corporation reported net income of $195,000, or 4.4 cents per share, on revenue of $5,656,000 compared to a net income of $16,000, or 0.4 cents per share, on revenue of $4,616,000 for the 2018 fiscal year. For the three months ended December 31, 2019, the Corporation reported a net loss of $151,000, or 3.5 cents per share, on revenue of $947,000 compared to a net income of $189,000, or 4.3 cents per share, on revenue of $1,708,000, for the same period...

HOUSTON, April 08, 2020 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (the “Company”), the holding company of Allegiance Bank (the “Bank”), today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and out of concern for the health and well-being of the Company’s employees and shareholders, its Annual Meeting of Shareholders, to be held on Thursday, April 23, 2020 at 1:30 p.m. Central Time, has been changed to a virtual meeting. Shareholders will not be able to attend the Annual Meeting in person this year.Shareholders are entitled to participate in the Annual Meeting if they were a registered shareholder as of the close of business on February 28, 2020, the record date, or hold a legal proxy for the meeting provided by the bank, broker or other nominee that...